UBS Group
GHRS icon

UBS Group’s GH Research GHRS Stock Holding History

UBS Group’s Portfolio GHRS Stock Details GHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.8M Buy
412,416
+49,035
+13% +$753K ﹤0.01% 3912
2025
Q4 		$4.61M Sell
363,381
-148,083
-29% -$2.02M ﹤0.01% 4110
2025
Q3 		$7.31M Buy
511,464
+52,882
+12% +$740K ﹤0.01% 3631
2025
Q2 		$5.59M Buy
458,582
+10,648
+2% +$117K ﹤0.01% 3757
2025
Q1 		$4.94M Buy
447,934
+426,707
+2,010% +$4.77M ﹤0.01% 3788
2024
Q4 		$149K Buy
21,227
+20,581
+3,186% +$165K ﹤0.01% 6633
2024
Q3 		$4.32K Buy
+646
New +$6.62K ﹤0.01% 8153
2024
Q2 		– Sell
-209
Closed -$2.23K – 9720
2024
Q1 		$2.23K Buy
+209
New +$1.66K ﹤0.01% 7955
2022
Q2 		– Sell
-100
Closed -$2K – 10541
2022
Q1 		$2K Buy
+100
New +$1.77K ﹤0.01% 9630
2021
Q3 		– Sell
-335
Closed -$7K – 9737
2021
Q2 		$7K Buy
+335
New +$6.84K ﹤0.01% 8326

Other funds holding GHRS

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
TCA
Troluce Capital Advisors Dorado, Puerto Rico $1.63B AUM 37.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

UBS Group's GHRS Position: Q1 2026 in Review

UBS Group increased its GH Research (GHRS) stake by 13% in Q1 2026, buying an estimated $753K and bringing the position to 412,416 shares worth $5.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3912.

UBS Group first reported a position in GHRS in Q2 2021 and has held it in 10 quarters since. The position peaked at $7.31M in Q3 2025. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • UBS Group held 412,416 shares of GH Research worth $5.8M as of Q1 2026.
  • UBS Group bought 49,035 GH Research shares in Q1 2026, an estimated $753K.
  • GH Research made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3912 holding.
  • UBS Group first reported a position in GH Research in Q2 2021 and has held it in 10 quarters since.
  • UBS Group's GH Research position peaked at $7.31M in Q3 2025.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.